Description
Patients with mixed dyslipidemia is treated with the atorvastatin/ fenofibrate FDC which had a significantly greater reduction in TG than those treated with atorvastatin 40 mg or higher-dose fenofibrate. Treatment with the FDC was also associated with a significantly greater reduction in non-HDL-C compared with fenofibrate alone and a greater increase in HDL-C compared with atorvastatin alone. All treatments were generally well tolerated.
